{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:48:53Z","timestamp":1757310533556},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Systemic scleroderma (SSc) is an insidious autoimmune connective tissue disorder with multiorgan involvement. Renal involvement is one of the important causes of morbidity and mortality in scleroderma; however, nephrotic syndrome is reported rarely in association with SSc. We present a patient with SSc who developed focal segmental glomerulosclerosis (FSGS) as a complication of scleroderma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 59 year old Caucasian female patient, with a known history of diffuse systemic sclerosis from 8 years, presented to our clinic with symptoms of anasarca and weight gain. Her physical examination was unremarkable except for periorbital and extremity edema. Her biochemistry assessment revealed decreased serum albumin levels and elevated serum creatinine levels. A renal biopsy was performed, which showed histopathological patterns of FSGS type of nephrotic syndrome. After administration of high doses of steroid and rituximab in the course of her treatment for 6 months, her symptoms and proteinuria were improved without the occurrence of scleroderma renal crises.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>SSc is a complex multisystemic autoimmune disorder. SRC is the most prominent renal involvement in SSc, but other renal pathologies may also occur. Each patient should be precisely investigated since managing these renal conditions can differ significantly. Nephrotic syndrome is a rare complication of SSc, which could be managed with prompt diagnosis and steroid administration.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-023-04273-6","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T13:02:04Z","timestamp":1705323724000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nephrotic syndrome due to focal segmental glomerulosclerosis complicating scleroderma: a case report"],"prefix":"10.1186","volume":"18","author":[{"given":"Mahsa","family":"Mehdipour Dalivand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asghar","family":"Hadjiabbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Ramezanzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mahmood","family":"Habibzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimia","family":"Goudarzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Shahriarirad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habib","family":"Zayeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,15]]},"reference":[{"issue":"1","key":"4273_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, et al. Systemic sclerosis. Nat Rev Dis Primers. 2015;1(1):1\u201321.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"4273_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/kjm2.12505","volume":"38","author":"AH Rosendahl","year":"2022","unstructured":"Rosendahl AH, Sch\u00f6nborn K, Krieg T. Pathophysiology of systemic sclerosis (scleroderma). Kaohsiung J Med Sci. 2022;38(3):187\u201395.","journal-title":"Kaohsiung J Med Sci"},{"issue":"11","key":"4273_CR3","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.5664\/jcsm.8036","volume":"15","author":"BT Nokes","year":"2019","unstructured":"Nokes BT, Raza HA, Cartin-Ceba R, Lyng PJ, Krahn LE, Wesselius L, et al. Individuals with scleroderma may have increased risk of sleep-disordered breathing. J Clin Sleep Med. 2019;15(11):1665\u20139.","journal-title":"J Clin Sleep Med"},{"key":"4273_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.12703\/r\/10-43","volume":"10","author":"JL Zhu","year":"2021","unstructured":"Zhu JL, Black SM, Chen HW, Jacobe HT. Emerging treatments for scleroderma\/systemic sclerosis. Fac Rev. 2021;10:43.","journal-title":"Fac Rev."},{"key":"4273_CR5","doi-asserted-by":"publisher","DOI":"10.1159\/000507886","author":"M Scheen","year":"2023","unstructured":"Scheen M, Dominati A, Olivier V, Nasr S, De Seigneux S, Mekinian A, et al. Renal involvement in systemic sclerosis. Autoimmun Rev. 2023. https:\/\/doi.org\/10.1159\/000507886.","journal-title":"Autoimmun Rev."},{"issue":"4","key":"4273_CR6","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1159\/000507886","volume":"45","author":"M Chrabaszcz","year":"2020","unstructured":"Chrabaszcz M, Ma\u0142yszko J, Sikora M, Alda-Malicka R, Stochmal A, Matuszkiewicz-Rowinska J, et al. Renal involvement in systemic sclerosis: an update. Kidney Blood Press Res. 2020;45(4):532\u201348.","journal-title":"Kidney Blood Press Res"},{"issue":"11","key":"4273_CR7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrneph.2016.124","volume":"12","author":"TG Woodworth","year":"2016","unstructured":"Woodworth TG, Suliman YA, Li W, Furst DE, Clements P. Scleroderma renal crisis and renal involvement in systemic sclerosis. Nat Rev Nephrol. 2016;12(11):678\u201391.","journal-title":"Nat Rev Nephrol"},{"key":"4273_CR8","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1007\/s10067-018-4291-z","volume":"37","author":"X Li","year":"2018","unstructured":"Li X, Qian Y-Q, Liu N, Mu R, Zuo Y, Wang G-C, et al. Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study. Clin Rheumatol. 2018;37:3051\u20136.","journal-title":"Clin Rheumatol."},{"key":"4273_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s002960100131","volume":"21","author":"S Hirohata","year":"2001","unstructured":"Hirohata S, Ohse T, Takeuchi A, Hashimoto T. Systemic sclerosis complicated with nephrotic syndrome: relevance with antiribosomal P antibody. Rheumatol Int. 2001;21:40\u20133.","journal-title":"Rheumatol Int"},{"issue":"1","key":"4273_CR10","first-page":"89","volume":"3","author":"M Abdulrasheed","year":"2022","unstructured":"Abdulrasheed M, Ibrahim A, Umar A, Ahmed M. Nephrotic syndrome heralding scleroderma. J Med Basic Sci Res. 2022;3(1):89\u201394.","journal-title":"J Med Basic Sci Res"},{"issue":"6","key":"4273_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S2173-5743(07)70263-0","volume":"3","author":"MLV Feijoo","year":"2007","unstructured":"Feijoo MLV, Montero SR, Moreno PG, Gonz\u00e1lez LM, Gieb ER, Alonso JF, et al. Nephrotic syndrome in scleroderma. Reumatol Cl\u00edn (English Edition). 2007;3(6):270\u20132.","journal-title":"Reumatol Cl\u00edn (English Edition)"},{"issue":"9","key":"4273_CR12","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3899\/jrheum.111417","volume":"39","author":"M Caron","year":"2012","unstructured":"Caron M, Hudson M, Baron M, Nessim S, Group CSR, Steele R. Longitudinal study of renal function in systemic sclerosis. J Rheumatol. 2012;39(9):1829\u201334.","journal-title":"J Rheumatol."},{"key":"4273_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/538589","author":"VK Shanmugam","year":"2010","unstructured":"Shanmugam VK, Steen VD. Renal manifestations in scleroderma: evidence for subclinical renal disease as a marker of vasculopathy. Int J Rheumatol. 2010. https:\/\/doi.org\/10.1155\/2010\/538589.","journal-title":"Int J Rheumatol."},{"key":"4273_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e31827781fd","author":"T Qu\u00e9m\u00e9neur","year":"2013","unstructured":"Qu\u00e9m\u00e9neur T, Mouthon L, Cacoub P, Meyer O, Michon-Pasturel U, Vanhille P, et al. Systemic vasculitis during the course of systemic sclerosis: report of 12 cases and review of the literature. Medicine. 2013. https:\/\/doi.org\/10.1097\/MD.0b013e31827781fd.","journal-title":"Medicine"},{"key":"4273_CR15","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.rbr.2014.08.005","volume":"57","author":"SB Couto","year":"2017","unstructured":"Couto SB, Sallum AM, Henriques LS, Malheiros DM, Silva CA, Vaisbich MH. Nephrotic syndrome as the first manifestation of juvenile systemic scleroderma. Rev Bras Reumatol. 2017;57:613\u20135.","journal-title":"Rev Bras Reumatol"},{"issue":"25","key":"4273_CR16","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1056\/NEJMra1106556","volume":"365","author":"VD D'Agati","year":"2011","unstructured":"D\u2019Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med. 2011;365(25):2398\u2013411.","journal-title":"N Engl J Med"},{"issue":"7","key":"4273_CR17","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1093\/ndt\/gfq668","volume":"26","author":"LF Arias","year":"2011","unstructured":"Arias LF, Franco-Alzate C, Rojas SL. Tip variant of focal segmental glomerulosclerosis: outcome and comparison to \u2018not otherwise specified\u2019variant. Nephrol Dial Transplant. 2011;26(7):2215\u201321.","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"4273_CR18","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.2215\/CJN.12071018","volume":"13","author":"AZ Rosenberg","year":"2018","unstructured":"Rosenberg AZ, Kopp JB. Erratum: Focal segmental glomerulosclerosis (Clin J Am Soc Nephrol (2017), 12,502-517, 10.2215\/CJN. 05960616). Clin J Am Soc Nephrol. 2018;13(12):1889.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"4273_CR19","doi-asserted-by":"publisher","first-page":"13783","DOI":"10.1038\/s41598-019-50405-8","volume":"9","author":"W Winnicki","year":"2019","unstructured":"Winnicki W, Sunder-Plassmann G, Seng\u00f6lge G, Handisurya A, Herkner H, Kornauth C, et al. Diagnostic and prognostic value of soluble urokinase-type plasminogen activator receptor (suPAR) in focal segmental glomerulosclerosis and impact of detection method. Sci Rep. 2019;9(1):13783.","journal-title":"Sci Rep"},{"key":"4273_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7689254","author":"E K\u00f6nigshausen","year":"2017","unstructured":"K\u00f6nigshausen E, Sellin L. Recent treatment advances and new trials in adult nephrotic syndrome. BioMed Res Int. 2017. https:\/\/doi.org\/10.1155\/2017\/7689254.","journal-title":"BioMed Res Int"},{"issue":"4","key":"4273_CR21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000360908","volume":"39","author":"A Kronbichler","year":"2014","unstructured":"Kronbichler A, Kerschbaum J, Fernandez-Fresnedo G, Hoxha E, Kurschat CE, Busch M, et al. Rituximab treatment for relapsing minimal change disease and focal segmental glomerulosclerosis: a systematic review. Am J Nephrol. 2014;39(4):322\u201330.","journal-title":"Am J Nephrol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04273-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-023-04273-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04273-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T14:03:21Z","timestamp":1705327401000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-023-04273-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,15]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4273"],"URL":"https:\/\/doi.org\/10.1186\/s13256-023-04273-6","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,15]]},"assertion":[{"value":"12 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient in our case. The purpose of this research was completely explained to the patients and they were assured that their information will be kept confidential by the researcher.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}